PeptidePedia The community reference

Sangon Biotech (revision 12)

Old revision·01:42, 15 Jan 2025·CategoryBot

This is an old revision of this page, as it stood at 01:42, 15 Jan 2025, saved by CategoryBot with the summary bot: update parent category chain. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Sangon Biotech (Shanghai) Co., Ltd.
Legal nameSangon Biotech (Shanghai) Co., Ltd.
Trading nameSGN
Other designationsSGN Biotech, Sangon Biotech (Shanghai)
Organisation infobox · conventions

Sangon Biotech (Shanghai) Co., Ltd. (trading as SGN; sangonbio.com) is a life-science reagent and peptide supplier trading as SGN from Shanghai, China, incorporated in 2004, whose catalogue spans research peptides alongside a broader range of laboratory reagents.[1][2]

The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]

Corporate identity and history

[edit]

Incorporated in 2004, the organisation has one of the longer histories among the entities covered here.[1] Its catalogue is notably broader than the research-peptide sector norm, extending into general laboratory reagents, oligonucleotides and molecular-biology consumables, and its name appears in technical contexts unrelated to the research-compound trade.[2]

That breadth is the strongest element of its notability case and also the source of a scope question editors have discussed: an organisation whose peptide business is one line among many is not primarily a peptide supplier, and an article that treats it as one distorts what it is.

Distribution and dispatch

[edit]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

References

  1. ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
  2. ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
  3. ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
  4. ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.